The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

Documenti analoghi

• The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
  di: Prevo, R, et al.
  Pubblicazione: (2012)
• ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
  di: Fokas, E, et al.
  Pubblicazione: (2013)
• Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
  di: Fokas, E, et al.
  Pubblicazione: (2012)
• Targeting ATR in DNA damage response and cancer therapeutics.
  di: Fokas, E, et al.
  Pubblicazione: (2014)
• Targeting ATR in DNA damage response and cancer therapeutics
  di: Fokas, E, et al.
  Pubblicazione: (2014)